Disclaimer

*Results may vary. The information in this site is NOT to be construed as medical advice. Cirrhosis of the liver is a serious condition and if you have it, you should see a doctor. I am not a doctor and am not able to dispense medical advice. My husband saw a doctor (many of them) and they were able to do things for him that I could not. However, they were unable to recommend alternative treatments, and in MY OPINION they were VERY beneficial to my husband, so I am providing some of that information here. My husband and I tried all of these alternative therapies at our own risk, and if you try them you will be doing the same. At your own risk. No promises are made in this blog. I am not saying there is a cure for cirrhosis or any other condition. However, I believe most people can get well, like my husband did. My husband is alive, happy, productive, functional and has his energy back. He no longer worries about having to go on disability or getting a $577,000 liver transplant. Cirrhosis is a serious condition. He is currently in the fibrosis stage (Stage 2 liver disease), which is still serious. I cannot guarantee you will have the same results. I just want you to know about what worked well for my husband. I hope you will share what you learned with others, and share your story with us as well. This blog was made for YOU! Thanks for visiting!

Saturday, August 16, 2014

An interesting article about reducing Liver Fibrosis

Thought this was a good article that explains how the fibrotic tissue in cirrhosis is developed, and how it may be reversed.

I had to look up a few words... (highlighted in orange in the article)

"Stellate" means
  1. arranged in a radiating pattern like that of a star.

"Quiescent" means 
 in a state or period of inactivity or dormancy.

The original article can be found here:
http://ucsdnews.ucsd.edu/pressrelease/scarring_cells_revert_to_inactive_state_as_liver_heals/

Scarring Cells Revert To Inactive State As Liver Heals
Research with mice reveals possible strategy to reverse fibrosis in liver and other organs



A photomicrograph of cirrhotic liver tissue, with extensive fibrotic scarring (stained blue).


A photomicrograph of cirrhotic liver tissue, with extensive fibrotic scarring (stained blue).
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, report that significant numbers of myofibroblasts – cells that produce the fibrous scarring in chronic liver injury – revert to an inactive phenotype as the liver heals. The discovery in mouse models could ultimately help lead to new human therapies for reversing fibrosis in the liver, and in other organs like the lungs and kidneys.

The work is published in the May 7, 2012 online Early Edition of the Proceedings of the National Academy of Sciences.

“The take-away message is two-fold,” said David A. Brenner, MD, vice chancellor for Health Sciences, dean of the UC San Diego School of Medicine and senior author of the paper. “First, we’ve shown that liver fibrosis is markedly reversible and we now better understand how it happens. Second, we can start looking for ways to direct active myofibroblasts to stop producing scar, and become inactive. We can focus on developing drugs that promote cell change and regression. It raises the bar for prospective treatment tremendously.”

Liver fibrosis is the 12th leading cause of death in the United States. It is the result of chronic liver injury caused by such agents as the hepatitis B and C viruses, alcoholic liver disease and non-alcoholic steatohepatitis. The condition is manifested by extensive scarring of liver tissue and the organ’s progressive inability to filter body toxins. Liver fibrosis precedes the development of liver cancer. Often, the only treatment for end-stage liver fibrosis is an organ transplant.

Fibrosis begins when infectious agents or excessive alcohol consumption trigger activation of hepatic stellate cells (HSCs), which normally act as quiescent storage units for nutrients like vitamin A in the liver. Once activated, these HSCs acquire characteristics of another cell type called myofibroblasts, which are characterized by their abundant production of extracellular matrix proteins such as collagen. These proteins accumulate as scar tissue, rendering the organ progressively dysfunctional.

However, if the source of the liver injury is successfully treated or eliminated, the liver can repair itself. In part, this is due to the activated HSCs undergoing apoptosis (programmed cell death) and being removed by other cells. But UC San Diego scientists say that, in tests using a mouse model, as many as half of all activated HSCs persist. They do not die, but rather revert to an inactive phenotype during fibrotic regression.

“After one month of regression, these cells have stopped producing collagen. They’ve upregulated some of the genes associated with quiescence and returned to their normal location in the liver,” said Tatiana Kisseleva, MD, PhD, an assistant research scientist and first author of the study.

It’s not clear why these myofibroblasts survive. Also, scientists note the reverted myofibroblasts do not completely return to their original quiescent state. “They’re still more susceptible to repetitive injury than original quiescent HSCs,” said Kisseleva, who noted future tests will investigate whether additional reversion occurs with more time.

Kisseleva suggested the findings present another avenue for treating liver fibrosis, especially in possibly reverting fibrosis and cirrhosis, which accounts for roughly 27,000 deaths in the United States annually.

Fibrosis occurs in other organs as well, such as the kidneys and lungs, with comparable deadly effect. Recent studies indicate fibrotic reversibility in these organs as well. “Our findings are applicable to other fibrosing organs,” said Kisseleva. “Instead of killing damaged cells, we might be able to de-activate them and revert them to healthy originals.”

Co-authors of the study are Min Cong, Chunyan Jiang, Keiko Iwaisako, Brian Scott and Wolfgang Dillmann, Department of Medicine, UC San Diego; YongHan Paik, Department of Medicine,  UC San Diego and Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, South Korea; David Scholten, Department of Medicine, UC San Diego and Department of Medicine III, University Hospital Aachen, Germany; Thomas Moore-Morris and Sylvia M. Evans, Skaggs School of Pharmacy and Pharmaceutical Science, UC San Diego; Hidekazu Tsukamoto, Keck School of Medicine, University of Southern California.






CLICK HERE TO FIND AN ALCOHOLICS ANONYMOUS CHAPTER IN YOUR AREA

CLICK ON THESE LINKS FOR MY OTHER POSTS 
to learn about:

Please note: I am not a doctor and I am only able to tell you what I have learned by doing my own research on the internet, and share with you the things that have worked for my husband. Please remember that Liver Cirrhosis is a very serious disease so I am not saying, do not see a doctor. Doctors have helped my 
husband a lot. But I believe it is wise to do as much research as you can, and find out why 
they are giving you every one of the medications and treatments they are giving you. 
I believe they do not always know about or understand every treatment option that is available, 
and there are many good options out there that can help.
Your health is ultimately your own responsibility, above anyone else's.

Best of luck to you!!!
If you have something to share, please feel free to leave a comment on this blog.




Keywords: healing liver cirrhosis, how to heal liver cirrhosis, cirrhosis cure, AA, alcoholics anonymous, how to beat cirrhosis, how to stop drinking, how i healed liver cirrhosis, heal yourself from liver cirrhosis, how to heal fibrosis, how to reverse cirrhosis, how to reverse fibrosis, cirrhosis cure, cure liver cirrhosis, the cirrhosis bible, book on cirrhosis, best foods to eat for cirrhosis, how to cure cirrhosis of the liver, how to heal cirrhosis of the liver, how to reverse cirrhosis of the liver, how to heal your liver, how to heal my liver, the ezra protocol, end stage cirrhosis, meld score, end stage liver disease, acid reflux, antacids, dangers of proton pump inhibitors, paracentesis, parascentesis, dangers of proton pump inhibitors pantoprazole omeprazole protonix vimovo Protonix Nexium prevacid prilosec Dexilant Aciphex PPi's acid reflux GERD, heartburn, FDA warning 

No comments:

Post a Comment